Growing Adoption of Biosimilars Reshapes the Canada Pharmaceutical Market Landscape The Canada Pharmaceutical Market is entering a new phase of growth as pharmaceutical companies increasingly focus on advanced therapies, specialty medicines, and innovative drug development programs. According to Polaris Market Research, the market is expected to reach USD 88.11 billion by 2032, growing from USD 51.72 billion in 2024 at a CAGR of 6.9%. Rising healthcare needs, an aging...
0 Μοιράστηκε
17 Views
0 Προεπισκόπηση